Therefore, the change ratio of ATP1A1 expression (SILAC ratio 1/SILAC ratio 2) was 0.27 between RCTs and PKTs, which indicated that this protein was a 3.7-fold decrease in RCC tissues compared to noncancerous counterparts. This evidence concerns the gene ATP1A1 and renal cell carcinoma.